Corrigendum to: Enterococcus faecalis promotes osteoclastogenesis and semaphorin 4D expression (Innate Immunity, (2015), 21, 7, (726-735), 10.1177/1753425915593162);Enterococcus faecalis promotes osteoclastogenesis and semaphorin 4D expression

Innate Immunity

Volumn 21, Issue 7, 2015, Pages 726-735

  Wang, Shuai ^a   Deng, Zuhui ^a,b   Seneviratne, Chaminda J ^c   Cheung, Gary Sp ^a   Jin, Lijian ^a   Zhao, Baohong ^d,e   Zhang, Chengfei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MSU BITUniversity   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Enterococcus faecalis; MAPK signaling pathways; osteoclasts; receptor activator of nuclear factor kappa B ligand; tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; SEMAPHORIN; SEMAPHORIN 4D; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ACID PHOSPHATASE; CD100 ANTIGEN; ISOENZYME; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NFATC1 PROTEIN, MOUSE; TARTRATE-RESISTANT ACID PHOSPHATASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BONE DESTRUCTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; MULTINUCLEAR CELL; MURINE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRECURSOR; PROTEIN EXPRESSION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TOOTH PERIAPICAL DISEASE; TOOTH ROOT CANAL; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; CELL LINE; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; GRAM POSITIVE INFECTION; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; PATHOPHYSIOLOGY; PERIAPICAL PERIODONTITIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACID PHOSPHATASE; ANIMALS; ANTIGENS, CD; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; ENTEROCOCCUS FAECALIS; GENE EXPRESSION REGULATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; ISOENZYMES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PERIAPICAL PERIODONTITIS; RANK LIGAND; SEMAPHORINS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84942117005     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425920926284     Document Type: Erratum

References (45)

1. Siqueira JF Jr, Rocas IN, Souto R, et al. Actinomyces species, streptococci, and Enterococcus faecalis in primary root canal infections. J Endod 2002; 28: 168-172.
2. Rocas IN, Siqueira JF Jr, Santos KR,. Association of Enterococcus faecalis with different forms of periradicular diseases. J Endod 2004; 30: 315-320.
3. Nair PN,. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 2004; 15: 348-381.
4. Matsuo K, Irie N,. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008; 473: 201-209.
5. Mundy GR, Elefteriou F,. Boning up on ephrin signaling. Cell 2006; 126: 441-443.
6. Hayashi N, Yamaguchi M, Nakajima R, et al. T-helper 17 cells mediate the osteo/odontoclastogenesis induced by excessive orthodontic forces. Oral Dis 2012; 18: 375-388.
7. Vaananen HK, Laitala-Leinonen T,. Osteoclast lineage and function. Arch Biochem Biophys 2008; 473: 132-138.
8. Chen B, Wu W, Sun W, et al. RANKL expression in periodontal disease: where does RANKL come from? Biomed Res Int 2014; 2014: 731039-731039.
9. Asagiri M, Takayanagi H,. The molecular understanding of osteoclast differentiation. Bone 2007; 40: 251-264.
10. Takami M, Woo JT, Nagai K,. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production. Cell Tissue Res 1999; 298: 327-334.
11. Lam J, Takeshita S, Barker JE, et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106: 1481-1488.
12. Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000; 191: 275-286.
13. Islam S, Hassan F, Tumurkhuu G, et al. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem Biophys Res Commun 2007; 360: 346-351.
14. Jiang J, Li H, Fahid FS, et al. Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide. J Endod 2006; 32: 742-746.
15. Kirstein B, Chambers TJ, Fuller K,. Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior. J Cell Biochem 2006; 98: 1085-1094.
16. Fujisaki K, Tanabe N, Suzuki N, et al. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Life Sci 2007; 80: 1311-1318.
17. Takayanagi H, Kim S, Koga T, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002; 3: 889-901.
18. Matsumoto M, Kogawa M, Wada S, et al. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem 2004; 279: 45969-45979.
19. Takegahara N, Takamatsu H, Toyofuku T, et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol 2006; 8: 615-622.
20. Negishi-Koga T, Shinohara M, Komatsu N, et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med 2011; 17: 1473-1480.
21. Aurandt J, Li W, Guan KL,. Semaphorin 4D activates the MAPK pathway downstream of plexin-B1. Biochem J 2006; 394: 459-464.
22. Dacquin R, Domenget C, Kumanogoh A, et al. Control of bone resorption by semaphorin 4D is dependent on ovarian function. PLoS One 2011; 6: e26627-e26627.
23. Zhu X, Wang Q, Zhang C, et al. Prevalence, phenotype, and genotype of Enterococcus faecalis isolated from saliva and root canals in patients with persistent apical periodontitis. J Endod 2010; 36: 1950-1955.
24. Wang QS, Cui YL, Wang YF, Chi W,. Effects of compounds from bi-qi capsule on the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Ethnopharmacol 2011; 136: 480-487.
25. Li C, Shi C, Kim J, et al. Erythropoietin promotes bone formation through ephrinb2/EphB4 signaling. J Dent Res 2015; 94: 455-463.
26. Franco GC, Kajiya M, Nakanishi T, et al. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo. Exp Cell Res 2011; 317: 1454-1464.
27. Fratini E, Licursi V, Artibani M, et al. Dose-dependent onset of regenerative program in neutron irradiated mouse skin. PLoS One 2011; 6: e19242-e19242.
28. Seneviratne CJ, Wang Y, Jin L, et al. Proteomics of drug resistance in Candida glabrata biofilms. Proteomics 2010; 10: 1444-1454.
29. Jimi E, Nakamura I, Duong LT, et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 1999; 247: 84-93.
30. Azuma Y, Kaji K, Katogi R, et al. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000; 275: 4858-4864.
31. Li X, Okada Y, Pilbeam CC, et al. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000; 141: 2054-2061.
32. Suzawa T, Miyaura C, Inada M, et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000; 141: 1554-1559.
33. Pfeilschifter J, Chenu C, Bird A, et al. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 1989; 4: 113-118.
34. Kurihara N, Bertolini D, Suda T, et al. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990; 144: 4226-4230.
35. Kobayashi Y, Mizoguchi T, Take I, et al. Prostaglandin E-2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem 2005; 280: 11395-11403.
36. Kim J, Yang J, Park OJ, et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. J Bone Miner Res 2013; 28: 2381-2391.
37. Muthukumar R, Alexandar V, Thangam B, Ahmed SS,. A systems biological approach reveals multiple crosstalk mechanism between gram-positive and negative bacterial infections: an insight into core mechanism and unique molecular signatures. PLoS One 2014; 9: e89993-e89993.
38. Quinn JM, Gillespie MT,. Modulation of osteoclast formation. Biochem Biophys Res Commun 2005; 328: 739-745.
39. Miyamoto T,. Regulators of osteoclast differentiation and cell-cell fusion. Keio J Med 2011; 60: 101-105.
40. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13: 2412-2424.
41. Matsuo K, Galson DL, Zhao C, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 2004; 279: 26475-26480.
42. Kim MS, Day CJ, Selinger CI, et al. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem 2006; 281: 1274-1285.
43. Cuetara BL, Crotti TN, O'Donoghue AJ, McHugh KP,. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim 2006; 42: 182-188.
44. Matsumoto M, Sudo T, Maruyama M, et al. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett 2000; 486: 23-28.
45. Lee SE, Woo KM, Kim SY, et al. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 2002; 30: 71-77.